SARS-CoV-2 Vaccine Acceptance: We May Need to Choose Our Battles

被引：18
|
作者：
Buttenheim, Alison M. [1 ,2 ]
机构：
[1] Univ Penn, Ctr Hlth Incent & Behav Econ, Sch Nursing, Philadelphia, PA 19104 USA
[2] Univ Penn, Leonard Davis Inst, Philadelphia, PA 19104 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2020年 / 173卷 / 12期
关键词：
D O I：
10.7326/M20-6206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1018 / 1019
页数：2
相关论文
共 50 条
  • [41] Explanatory factors on the acceptance of SARS-CoV-2 vaccine from consumer's behaviour perspective
    de Andres Sanchez, Jorge
    Arias-Oliva, Mario
    Pelegrin-Borondo, Jorge
    Rua, Orlando Lima
    REVISTA ESPANOLA DE SALUD PUBLICA, 2021, 95
  • [42] Factors associated with the willingness and acceptance of SARS-CoV-2 vaccine from adult subjects in China
    Liu, Di
    Luo, Lan
    Xie, Fangfei
    Yu, Zengli
    Ma, Zheng Feei
    Wang, Yun
    Wan, Zhongxiao
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2405 - 2414
  • [43] SARS-COV-2 VACCINE ACCEPTANCE AND ASSOCIATED PSYCHOLOGICAL FACTORS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES
    Sugawara, H.
    Doi, H.
    Iwasaki, T.
    Nakayama, Y.
    Nishida, Y.
    Gon, Y.
    Kamakura, M.
    Ohbori, K.
    Sakane, N.
    Nakamura, N.
    Utsumi, T.
    Morinobu, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 925 - 926
  • [44] SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study
    Ko, Tina
    Dendle, Claire
    Woolley, Ian
    Morand, Eric
    Antony, Anna
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4048 - 4056
  • [45] SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
    Scialo, Filippo
    Vitale, Maria
    Daniele, Aurora
    Nigro, Ersilia
    Perrotta, Fabio
    Gelzo, Monica
    Iadevaia, Carlo
    Cerqua, Francesco Saverio
    Costigliola, Adriano
    Allocca, Valentino
    Amato, Felice
    Pastore, Lucio
    Castaldo, Giuseppe
    Bianco, Andrea
    BIOMEDICINES, 2021, 9 (06)
  • [46] Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau, Noam
    Yahav, Dafna
    Shepshelovich, Daniel
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1322 - 1325
  • [47] How we prepared our operating theatre for patients with SARS-CoV-2 virus
    Rymarowicz, Justyna
    Pedziwiatr, Michal
    Major, Piotr
    Nowakowski, Michal
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2021, 16 (01) : 117 - 122
  • [48] Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
    Le Bert, Nina
    Samandari, Taraz
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (02) : 159 - 170
  • [49] Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
    Nina Le Bert
    Taraz Samandari
    Cellular & Molecular Immunology, 2024, 21 : 159 - 170
  • [50] Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose
    Claro, Franklin
    Silva, Douglas
    Rodriguez, Melissa
    Rangel, Hector Rafael
    de Waard, Jacobus H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 111 : 261 - 266
12345